Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease
Clinical trial NCT05447494 · UNKNOWN
Trial details
- NCT number
- NCT05447494
- Sponsor
- CANbridge (Suzhou) Bio-pharma Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2024-11-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.